- $67.86bn
- $85.61bn
- $6.59bn
- 94
- 21
- 93
- 79
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 52 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5,223 | 5,103 | 4,798 | 5,429 | 6,585 |
Cost of Revenue | |||||
Gross Profit | 2,899 | 2,694 | 2,549 | 3,106 | 3,860 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,300 | 3,380 | 3,075 | 3,208 | 3,718 |
Operating Profit | 1,924 | 1,723 | 1,723 | 2,221 | 2,867 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,063 | 740 | 715 | 1,127 | 1,716 |
Provision for Income Taxes | |||||
Net Income After Taxes | 841 | 653 | 681 | 866 | 1,299 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 890 | 699 | 680 | 866 | 1,298 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 779 | 514 | 607 | 780 | 1,260 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 15.4 | 10.2 | 11.2 | 13.6 | 23 |
Special Dividends per Share |